Philips And UMCG Launch Five-Year EXIT-CVD Project With 42 Partners In 17 Countries, 22 Clinical Studies Of 14,000+ Patients, EUR 27.6M Budget
Five-year research project unites 42 public and private partners across 17 countries to conduct 22 clinical studies involving 14,000+ patients; first patients will be enrolled this monthProject aims to help cardiac
Share
Why It Matters
Philips is joining a big heart disease research project with 42 partners worldwide. This shows the company is investing in important medical work that could help patients.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.